Researchers uncover how breast cancer cells become resistant to therapy

by Molly Chiu,Baylor College of MedicineCredit: Unsplash/CC0 Public DomainAbout one-fourth of recurrent estrogen receptor-positive (ER+) breast cancers lose ER expression, which renders them res

Updated on: February 24,2024

Researchers uncover how breast cancer cells become resistant to therapy

by Molly Chiu,Baylor College of MedicineCredit: Unsplash/CC0 Public DomainAbout one-fourth of recurrent estrogen receptor-positive (ER+) breast cancers lose ER expression, which renders them res

Updated on:February 24,2024

New biomarker strategy devised to screen for, diagnose deadly heart complication from cancer treatment

byUniversity of MichiganCredit: Unsplash/CC0 Public DomainResearchers at Michigan Medicine have devised a new biomarker-based strategy to screen for a rare and deadly complication caused by mono

Updated on: January 12,2024

New biomarker strategy devised to screen for, diagnose deadly heart complication from cancer treatment

byUniversity of MichiganCredit: Unsplash/CC0 Public DomainResearchers at Michigan Medicine have devised a new biomarker-based strategy to screen for a rare and deadly complication caused by mono

Updated on:January 12,2024

New multimodal signature could predict immunotherapy success

byUniversity of InnsbruckCredit:iScience(2024). DOI: 10.1016/j.isci.2024.110529An international team of researchers led by Francesca Finotello from the Digital Science Center (DiSC)

Updated on: September 27,2024

New multimodal signature could predict immunotherapy success

byUniversity of InnsbruckCredit:iScience(2024). DOI: 10.1016/j.isci.2024.110529An international team of researchers led by Francesca Finotello from the Digital Science Center (DiSC)

Updated on:September 27,2024

Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe c-Met-directed antibody-drug conjugate telisotuzumab vedotin demonstrated durable responses and an accepta

Updated on: September 27,2024

Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe c-Met-directed antibody-drug conjugate telisotuzumab vedotin demonstrated durable responses and an accepta

Updated on:September 27,2024

Beating cancer-related fatigue with personalized interventions

byUniversity of TwenteFlow diagram of selection of eligible studies. Credit:European Journal of Cancer Care(2022). DOI: 10.1111/ecc.13754After diagnosis and treatment of breast cance

Updated on: January 07,2024

Beating cancer-related fatigue with personalized interventions

byUniversity of TwenteFlow diagram of selection of eligible studies. Credit:European Journal of Cancer Care(2022). DOI: 10.1111/ecc.13754After diagnosis and treatment of breast cance

Updated on:January 07,2024

Continuity of care needed from the 'front of the pathway' to the back for cancer survivors, reports study

byUniversity of OtagoCredit: Pixabay/CC0 Public DomainAfter undergoing cancer treatment, many survivors deal with a range of psycho-social and physical issues but support for them is limited, ne

Updated on: January 16,2024

Continuity of care needed from the 'front of the pathway' to the back for cancer survivors, reports study

byUniversity of OtagoCredit: Pixabay/CC0 Public DomainAfter undergoing cancer treatment, many survivors deal with a range of psycho-social and physical issues but support for them is limited, ne

Updated on:January 16,2024

An unexpected T cell exhaustion factor driving cancer immunotherapy resistance

by The University of Hong KongGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111647A research team from the LKS Faculty of Medicine, the University of Hong

Updated on: January 30,2024

An unexpected T cell exhaustion factor driving cancer immunotherapy resistance

by The University of Hong KongGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111647A research team from the LKS Faculty of Medicine, the University of Hong

Updated on:January 30,2024

Prostate cancer: Can AI help to avoid unnecessary biopsies?

byGerman Cancer Research CenterRisk stratification example from the test cohort: a 66-year-old male presents with negative DRE, PSA elevation to 6.2 ng/mL, prostate volume of 82.5 mL, and PSAD o

Updated on: August 27,2024

Prostate cancer: Can AI help to avoid unnecessary biopsies?

byGerman Cancer Research CenterRisk stratification example from the test cohort: a 66-year-old male presents with negative DRE, PSA elevation to 6.2 ng/mL, prostate volume of 82.5 mL, and PSAD o

Updated on:August 27,2024

Researchers describe a molecular strategy that helps prevent tumour formation in mice

by The Spanish National Cancer Research CentreCredit: CNIOThe body's process for manufacturing fatty acids is regulated by the enzyme FASN. In normal cells, this is not a very active process—

Updated on: June 08,2024

Researchers describe a molecular strategy that helps prevent tumour formation in mice

by The Spanish National Cancer Research CentreCredit: CNIOThe body's process for manufacturing fatty acids is regulated by the enzyme FASN. In normal cells, this is not a very active process—

Updated on:June 08,2024

Aerobic activity can reduce the risk of metastatic cancer by 72%

by Tel Aviv UniversityCredit: Pixabay/CC0 Public DomainA new study at Tel Aviv University found that aerobic exercise can reduce the risk of metastatic cancer by 72%. According to the researchers

Updated on: February 23,2024

Aerobic activity can reduce the risk of metastatic cancer by 72%

by Tel Aviv UniversityCredit: Pixabay/CC0 Public DomainA new study at Tel Aviv University found that aerobic exercise can reduce the risk of metastatic cancer by 72%. According to the researchers

Updated on:February 23,2024

Bone cells suppress cancer metastases

by Thomas Jefferson UniversityCredit: CC0 Public DomainIn breast cancer, there are cases of women and men whose cancer returns in their bones 20-30 years after they were treated for their primary

Updated on: March 30,2024

Bone cells suppress cancer metastases

by Thomas Jefferson UniversityCredit: CC0 Public DomainIn breast cancer, there are cases of women and men whose cancer returns in their bones 20-30 years after they were treated for their primary

Updated on:March 30,2024

Tracking the epigenetic evolution of a cancer, cell by cell

by Weill Cornell Medical CollegeDr. Dan Landau. Credit: Rene PerezA powerful new set of scientific tools developed by Weill Cornell Medicine and New York Genome Center (NYGC) researchers enables

Updated on: May 23,2024

Tracking the epigenetic evolution of a cancer, cell by cell

by Weill Cornell Medical CollegeDr. Dan Landau. Credit: Rene PerezA powerful new set of scientific tools developed by Weill Cornell Medicine and New York Genome Center (NYGC) researchers enables

Updated on:May 23,2024